Clario review (2026)
Headquarters Needs facts
Study fit
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
Explore documented featuresStudy fit
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Best for
- Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
Not for
- Teams that want to build and change their own study or need published pricing
Documented features
Best eCOA platformsFeature details
- Validated instrument library and licensing
Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.
Source- Regulatory compliance and track record
States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.
Source- Global scale and languages
Studies in over 120 countries and over 100 languages; 25 years of DCT and hybrid trials.
Source- Capture modes and integrations
BYOD, web or provisioned devices, plus pre-validated connected devices (CGM, glucose meters, Opal motion sensors) integrated with the eCOA device.
Source- Time to launch and self-service build
eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.
Source- Published pricing and terms
Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only.
Source
At a glance
- Headquarters
Needs facts
- Founded
Needs facts
- Pricing model
Not published
Source- Security certifications
ISO/IEC 27001:2022 and SOC 2 Type II
Source- Own-phone app (BYOD)
Yes; also web and provisioned devices
Source- Wearable data
Connected devices: CGM, glucose meters, Opal motion sensors
Source- Scale
Studies in 120+ countries and 100+ languages
Source- Regulatory track record
Says it supported 70% of FDA and EMA new drug approvals since 2015 (all endpoint types)
Source- eCOA instrument library
Pre-validated assessment libraries and Rapid Start catalog; eCOA Science Services team
Source- Fastest published build
eCOA Swift: early-phase oncology in as little as 2 weeks
Source
What it covers
- eCOA
- Cardiac safety
- Respiratory
- Medical imaging
- Precision Motion (wearable sensors)
- Eligibility
- Telehealth visits
Pricing
Pricing model: Not published
Alternatives to Clario
CastorStudy fit: biotech, device and academic teams that want eCOA, eConsent and EDC in one platform with a self-service option.Read the review
KayentisStudy fit: phase II-III sponsors that want a specialist eCOA vendor with site and patient helpdesk support.Read the review - Best eCOA platformsCompare 8 products by their documented features.See the eCOA list
Work at Clario and see something out of date? Send us a public source and we will check it and update the page.
Request a correction